GGrantIndex
Sort

326,823 grants matching clinical trial

UofL RBL Operations, Workforce Development and Pandemic Preparedness Research

$2,656,876
Kenneth E Palmer · University Of Louisville · UC7 · FY2025 · AI

ALZHEIMERS DISEASE RESEARCH CENTER

$2,656,846
University Of California San Diego · P50 · FY2001 · AG

PEDIATRIC ONCOLOGY GROUP STATISTICAL OFFICE

$2,656,698
University Of Florida · U10 · FY2002 · CA

Multiethnic Study of Type 2 Diabetes Genes

$2,656,555
David Altshuler · Broad Institute, Inc. · U01 · FY2011 · DK

University of Puerto Rico Clinical Trials Unit

$2,656,505
Carmen D Zorrilla · University Of Puerto Rico Med Sciences · U01 · FY2007 · AI

ACCF-STS Database Collaboration on the Comparative Effectiveness of PCI and CABG

$2,655,996
William S Weintraub · American College Of Cardiology · RC2 · FY2009 · HL

C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB Study

$2,655,299
Payam Nahid · University Of California, San Francisco · U01 · FY2024 · AI

SWOG Network Group Operations Center of the NCTN

$2,655,116
Charles D. Blanke · Oregon Health & Science University · U10 · FY2021 · CA

Columbia Collaborative HIV/AIDS Clinical Trials Unit

$2,654,816
Magdalena Elzbieta Sobieszczyk · Columbia University Health Sciences · UM1 · FY2022 · AI

HIV Prevention Trials Network: Network Laboratory

$2,654,477
Susan H Eshleman · Johns Hopkins University · U01 · FY2010 · AI

Cancer Immunotherapy Trials Network Central Operations and Statistical Center

$2,654,299
Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA

Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies

$2,654,146
Pamela J Bjorkman · California Institute Of Technology · P01 · FY2022 · AI

PROTON RADIATION THERAPY RESEARCH

$2,653,851
Thomas F Delaney · Massachusetts General Hospital · P01 · FY2012 · CA

Advancing brain health research through male germline editing in marmosets

$2,653,540
Brian Peter Hermann · University Of Texas San Antonio · U01 · FY2023 · DA

Regulatory Support for Cancer Prevention Agent Development

$2,653,402
Caroline Sigman · Ccs Associates, Inc. · N01 · FY2018 · CA

Preclinical Efficacy and Intermediate Endpoint Assays

$2,652,907
C. Roa · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2009 · CA

Gene Therapy Platform for Rare Diseases

$2,652,815
Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR

Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers

$2,652,771
Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2025 · DA

Pelvic floor Disorders Network-Data Coordinating Center

$2,652,472
Catherine A Spino · University Of Michigan At Ann Arbor · U01 · FY2009 · HD

Models For Tobacco Product Evaluation

$2,652,358
Dorothy K Hatsukami · University Of Minnesota · U19 · FY2012 · CA

Drug at the Right Place & Concentration: Optimizing Combination Vaginal Ring PrEP

$2,652,240
Betsy C. Herold · Albert Einstein College Of Medicine, Inc · U19 · FY2016 · AI

UT MD Anderson CCOP Research Base

$2,652,138
University Of Texas Md Anderson Can Ctr · U10 · FY2004 · CA

Chicago WIHS Consortium V (CWC)

$2,651,955
Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2014 · AI

Chemoprevention of Lung Cancer

$2,651,930
University Of Cincinnati · P01 · FY2004 · CA

Durban International Clinical Trials Unit

$2,651,567
Umesh G Lalloo · Ukzn Innovation · U01 · FY2010 · AI